Director/PDMR Shareholding

RNS Number : 0198U
Judges Scientific PLC
30 November 2021
 

Judges Scientific plc

Director/PDMR Shareholding

The Company has today issued 1,775 new ordinary shares of 5p each in the Company ("Ordinary Shares") pursuant to the exercise of options at a price of 1690 pence under the Company's Approved Share Option Scheme. The new Ordinary Shares are being issued under the Company's current blocklisting.

The options were exercised by Ralph Cohen, Non-Executive Director.

As a result of the exercise Ralph Cohen's resulting interest in the Company has increased by 1,775 shares to 66,116 Ordinary Shares representing 1.05% per cent. of the issued Ordinary share capital.  He holds no further options under the Company's Share Option Schemes.

Following the allotment of these shares, the enlarged issued Ordinary share capital will be 6,318,415 Ordinary Shares.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Ralph Cohen

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Exercise of options under the rules of the 2005 Approved Share Option Scheme

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1690p

 

1,775

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A (single transaction)

e)

 

Date of the transaction

 

 

29/11/21

f)

Place of transaction

Outside of a trading venue

 

 

Judges Scientific

 

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

 

Shore Capital (Nominated Adviser & Broker)

 

 

Stephane Auton

Iain Sexton

Tel: +44 (0) 20 7408 4090

 

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

William Hall

 

Media enquiries :

Alma PR (Financial Public Relations)

 

Tel : +44 (0) 20 3100 2222

 

 

Sam Modlin

Justine James

Joe Pederzolli 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGIBDBSDXDGBG
UK 100

Latest directors dealings